concern that clinical microbiology continues to rely heavily upon cultivation-based methods, but perhaps not surprising. The internal environmental conditions of the human body are seemingly more familiar to us than those that are external, the internal niches have been the subjects of frequent study, and there is certainly no dearth of known microbial pathogens. But we should not be so complacent.
When traditional diagnostic methods are rigorously applied to syndromes of suspected infectious etiology, such as pneumonia, encephalitis, lymphocyte-predominant meningitis, pericarditis, acute diarrhea, and sepsis, only a minority of cases can be explained microbiologically. In addition, a long list of chronic inflammatory diseases with features of infection remains poorly understood. Thus, it seems fair to speculate that the distribution of known pathogens in only 7 bacterial divisions and the absence of any known pathogens within the domain Archaea may represent an imperfect understanding of the true diversity of microbes capable of causing human disease.
Molecular Approaches for Microbial Pathogen Detection and Identification: Seeking Signatures
In an effort to avoid reliance on cultivation and to establish alternative and complementary approaches, one might view the goal in microbial detection and pathogen discovery as a quest to identify molecular signatures of infection. These signatures must be reliable for identifying a microorganism and for es- Genomic sequence is the most frequently used "currency" in the identification of microbial signatures, and broad-range (or consensus) polymerase chain reaction (PCR) is the most practical tool for generating this currency [5] . Furthermore, rDNA is among the most useful genome sequences from which organismal ancestry and interrelationships can be reliably inferred and pathogen discovery approaches designed [7, 8] . With recent improvements in the speed at which primary genome sequence can be acquired and analyzed, other detection or screening formats may become widely available and additional regions of microbial (and viral) genomes more commonly targeted. For example, high-density microarrays of oligonucleotides or amplified DNA products can be designed to screen complex pools of microbial nucleic acid for specific agents in a massively parallel and efficient manner [9] . This technical platform obviates the need to clone and sequence large numbers of variant microbial molecules. This is particularly relevant to the analysis of clinical specimens with a significant burden of "background" microorganisms (see further discussion below) and facilitates more sophisticated uses of pattern recognition analysis as a tool for microbial signature identification.
There 
Exploring the Human Microbiome in Health and Disease
Molecular technique surveys of the microbial communities associated with humans during states of health have belatedly been initiated. These surveys are important for a number of reasons. In addition to the numerous but poorly characterized beneficial effects of the endogenous microflora on human health, a proper understanding of community membership, relative abundance, and variations therein will be critical for recognizing potential pathogens and patterns that are predictive of disease.
The subgingival crevice in the mouth is one of the more intensively studied and better-understood colonized sites of the human body. Molecular surveys that used broad-range rDNA PCR suggest that 5007o-600Zo of the bacteria present at this site are distinct from all of those previously described at the taxonomic level of species?albeit, a term that is loosely defined One issue of particular importance concerns the complexity and widespread distribution of microbial sequence "background" or "noise" observed in the analysis of human clinical specimens (both experimental and biological). The distribution and nature of this sequence background still is not well characterized. Findings of bacterial rDNA in association with blood samples from healthy humans threatens to expand the extent of this problem into anatomic compartments that have been traditionally viewed as usually sterile [24] . A different perspective on this same apparent problem was provided in an analysis of expressed sequence tag libraries from human tissues [25, 26] . Some of these transcripts that were originally assumed to derive from the human genome appear on closer inspection to be of microbial origin. Whether some of these molecules were intrinsic to the original specimen or introduced later remains unclear, but some are easily attributed to agents that are common, persistent, or dormant infectious agents found within these human tissues.
The increasing availability of molecular pathogen discovery methods and the ease with which molecular signatures are generated create a pressing problem of a different kind. How can one build a convincing body of evidence for a causative role of the putative pathogen in a disease process when the pathogen is identified with molecular signatures and has not been isolated or purified? The issues surrounding this problem are familiar to epidemiologists and have been addressed during the past half century. One can adapt the same concepts to the kinds of data and techniques generated by modern approaches to pathogen detection and discovery [27] .
Among a variety of important steps in building an argument for causation, the ability to connect a signature physically to the sites of pathology where one most expects to find the putative disease agent is one helpful evidentiary component. Fluorescent in situ hybridization allows correlation of a specific sequence with areas of pathology and tissue-based microbial structures [28, 29] . This approach also examines signature "dosage" effects. Alternatively, anatomic sites of interest can be targeted specifically for signature detection by using laser capture microdissection [30, 31] .
Finally, the problems associated with clinical specimens can be substantial and potentially prohibitive as highlighted by results of the Unexplained Deaths Project [ 
